School of Medicine
Showing 431-440 of 938 Results
-
Gordon Li, MD
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery. -
Y. Howard Li
Postdoctoral Scholar, Ophthalmology
BioDr. Yuanhao Howard Li received his B.S. and Ph.D. in Brain and Cognitive Sciences at the University of Rochester, and he is currently a Postdoctoral Scholar in the Department of Ophthalmology at Stanford School of Medicine. His research is focused on how eye movements shape visual perception and how, in return, the oculomotor system utilizes eye movements to optimize visual information processing. His current projects apply eye-tracking and computational models to investigate and relationship between anatomical structure and oculomotor behavior in clinical populations with visual field impairment or abnormal motor control. This research aims to provide a better understanding of our brains and eyes, as well as potential applications in disease diagnosis and rehabilitation.
-
Jiawei Li
Postdoctoral Scholar, Cardiovascular Institute
BioMy research interests include organoids, engineering, and AI.
-
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
